Lilly Makes Billions of Weight-Loss Pills Before US Approval (1)

Oct. 28, 2025, 12:22 PM UTC

Eli Lilly & Co. has already produced billions of doses of its next-generation weight-loss pill, anticipating massive global demand ahead of a potential launch next year.

“We’ve already made, actually, billions of doses preparing for the launch,” Chief Executive Officer Dave Ricks said Monday at an event hosted by the Economic Club of Chicago. “That will make this sort of the ‘GLP-1 for all,’ and I think really makes a difference in human health at a global level.”

Lilly hasn’t yet submitted the pill, called orforglipron, to US regulators but expects to do so before the end of the year. ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.